We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$155M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$145M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$113M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$58M
5
CPA icon
Copa Holdings
CPA
+$49.3M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHH icon
2251
Schwab US REIT ETF
SCHH
$11.1B
$1M ﹤0.01%
48,166
+12,712
+36% +$269K
EE
2252
DELISTED
El Paso Electric Company
EE
$1M ﹤0.01%
17,575
-544
-3% -$33.3K
BCRH
2253
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$999K ﹤0.01%
97,982
+186
+0.2% +$1.95K
INST
2254
DELISTED
Instructure, Inc.
INST
$999K ﹤0.01%
28,220
+6,201
+28% +$254K
MDXG icon
2255
MiMedx Group
MDXG
$630M
$996K ﹤0.01%
161,109
-4,400
-3% -$19.9K
CRZO
2256
DELISTED
Carrizo Oil & Gas Inc
CRZO
$995K ﹤0.01%
39,474
+20,394
+107% +$527K
GKOS icon
2257
Glaukos
GKOS
$10.7B
$988K ﹤0.01%
15,227
-1,162
-7% -$57K
MYI icon
2258
BlackRock MuniYield Quality Fund III
MYI
$717M
$988K ﹤0.01%
81,796
-33,098
-29% -$411K
JRO
2259
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$987K ﹤0.01%
95,755
+8,032
+9% +$82.2K
XRLV
2260
DELISTED
Invesco S&P 500 ex-Rate Sensitive Low Volatility ETF
XRLV
$985K ﹤0.01%
27,178
+2,010
+8% +$71.5K
GLMD icon
2261
Galmed Pharmaceuticals
GLMD
$4.6M
$984K ﹤0.01%
+402
New +$941K
GRPM icon
2262
Invesco S&P MidCap 400 GARP ETF
GRPM
$507M
$984K ﹤0.01%
14,432
+173
+1% +$11.8K
JFR icon
2263
Nuveen Floating Rate Income Fund
JFR
$1.26B
$980K ﹤0.01%
94,325
-2,718
-3% -$28.1K
LMAT icon
2264
LeMaitre Vascular
LMAT
$1.89B
$980K ﹤0.01%
25,295
+5,010
+25% +$181K
AMPY icon
2265
Amplify Energy
AMPY
$187M
$979K ﹤0.01%
109,836
+57,692
+111% +$681K
AWP
2266
abrdn Global Premier Properties Fund
AWP
$358M
$979K ﹤0.01%
53,845
-41,517
-44% -$783K
VRA icon
2267
Vera Bradley
VRA
$95M
$979K ﹤0.01%
+64,184
New +$937K
BBT
2268
Beacon Financial Corp
BBT
$2.66B
$977K ﹤0.01%
23,996
+660
+3% +$27.4K
DCUD
2269
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
$977K ﹤0.01%
20,659
– –
APTI
2270
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$974K ﹤0.01%
26,365
+879
+3% +$32.7K
BME icon
2271
BlackRock Health Sciences Trust
BME
$577M
$972K ﹤0.01%
22,855
+9,033
+65% +$366K
LASR icon
2272
nLIGHT
LASR
$2.84B
$971K ﹤0.01%
43,700
+31,495
+258% +$985K
R icon
2273
Ryder
R
$9.92B
$971K ﹤0.01%
13,291
+2,478
+23% +$189K
MIY icon
2274
BlackRock MuniYield Michigan Quality Fund
MIY
$361M
$970K ﹤0.01%
78,233
+2,656
+4% +$34K
DOVA
2275
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$968K ﹤0.01%
46,139
-2,834
-6% -$67.5K
89 90
91
92 93

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.